Scholtz & Company, LLC Renalytix PLC Transaction History

Scholtz & Company, LLC

  • $207 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$17.91 - $34.78 $1.58 Million - $3.06 Million
-87,975 Closed
0 $0
Q2 2021

Aug 09, 2021
BUY
$23.56 - $34.25 $69,030 - $100,352
2,930 Added 3.45%
87,975 $2.72 Million
Q1 2021

May 17, 2021
BUY
$15.25 - $31.13 $1.05 Million - $2.15 Million
69,045 Added 431.53%
85,045 $2.18 Million
Q4 2020

Feb 12, 2021
BUY
$10.69 - $16.0 $171,040 - $256,000
16,000 New
16,000 $256,000

Others Institutions Holding RNLX

# of Institutions
29
Shares Held
3.91M
Call Options Held
13.7K
Put Options Held
0
View Full List

About Renalytix plc

RNLX Quotes by TradingView
  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Scholtz & Company, LLC Portfolio

Follow Scholtz & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scholtz & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scholtz & Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email